featured
Serum Levels of Anti-Transcriptional Intermediary Factor 1-γ Autoantibody as Prognostic Markers in Patients With Dermatomyositis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Seminars in Arthritis and Rheumatism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Serum levels of anti-transcriptional intermediary factor 1-γ autoantibody associated with the clinical, pathological characteristics and outcomes of patients with dermatomyositis
Semin. Arthritis Rheum. 2022 Apr 21;55(2022)152011, L Zhang, H Yang, H Yang, H Liu, X Tian, W Jiang, Q Peng, G Wang, X LuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.